Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 540 across all filing types
Latest filing 2019-02-01 Earnings Release
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Earnings Release 2019
Earnings Release Classification · 99% confidence The document is a short announcement (1507 chars) dated February 1, 2019, titled "Opjustering af omsætning og driftsresultat" (Revenue and Operating Result Adjustment). It explicitly states that the company is raising its expectations for revenue and EBITDA for the fiscal year 2018/19. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, often including guidance updates or revisions. It is not a full report (10-K or IR) nor a general regulatory filing (RNS), but a specific financial performance update. FY 2019
2019-02-01 English
Earnings Release 2019
Earnings Release Classification · 100% confidence The document is a short announcement (1864 characters) dated February 1, 2019, titled 'Opjustering af omsætning og driftsresultat' (Upgrade of revenue and operating profit). It explicitly states that the company is upgrading its expectations for revenue and EBITDA for the fiscal year 2018/19, providing new guidance figures. Crucially, it includes a section 'Vedhæftet fil' (Attached file) with a link to download the full 'Meddelelse 161'. This structure—a brief update announcing revised financial guidance and pointing to an attached/linked document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since it is an announcement about financial performance updates (guidance revision) rather than the full detailed report (like 10-K or IR) or just the initial highlights (ER), and given the short length and reference to an attachment, RPA is the most appropriate classification, as it announces the publication of the updated guidance/information. If the attached document were the full report, this wrapper would be RPA. FY 2019
2019-02-01 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document is titled "Aktietilbagekøbsprogram" (Share Buyback Program) and details specific transactions (date, number of shares, price, value) related to a share repurchase program executed between December 7 and December 20, 2018. This directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for Transaction in Own Shares (POS). Although it is a formal announcement (Meddelelse NR. 160), the content is the transaction detail itself, not just an announcement that a report is attached (which would suggest RPA/RNS).
2018-12-20 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 99% confidence The document is a formal announcement (MEDDELELSE NR. 160) detailing transactions conducted under a previously initiated share buyback program ('Aktietilbagekøbsprogram'). It provides specific dates, quantities of shares repurchased, and the total value, culminating in a statement about the company's current holding of treasury shares. This content directly corresponds to the definition of a company reporting transactions involving its own shares, which maps to the 'Transaction in Own Shares' category.
2018-12-20 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 99% confidence The document is a formal announcement (MEDDELELSE NR. 159) detailing the decision by ChemoMetec to implement a share buyback program ('Aktietilbagekøbsprogram') up to DKK 10 million. This action directly relates to the company acquiring its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares' (Code: POS). The document describes the mechanics, purpose (optimizing capital structure), and execution agent (Danske Bank) of the repurchase program.
2018-12-07 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document is titled "Aktietilbagekøbsprogram" (Share Buyback Program) and details the decision by ChemoMetec to repurchase up to 110,000 shares to optimize its capital structure. This directly relates to the company acquiring its own shares. The definition for Transaction in Own Shares (POS) is: "Report of the company buying back or selling its own shares (share repurchase/issuance).". Although the document announces the program, the content is the substance of the transaction itself, not just an announcement that a report is attached (which would lean towards RPA/RNS). Given the specific nature of the content detailing the buyback mechanics, POS is the most accurate classification. The document length (2391 chars) is short, but the content is the core announcement of the share transaction, not just a placeholder for a larger report.
2018-12-07 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.